Clinical journal of the American Society of Nephrology : CJASN
-
Clin J Am Soc Nephrol · Dec 2013
Multicenter StudyAssociation of elevated urinary concentration of renin-angiotensin system components and severe AKI.
Prognostic biomarkers that predict the severity of AKI at an early time point are needed. Urinary angiotensinogen was recently identified as a prognostic AKI biomarker. The study hypothesis is that urinary renin could also predict AKI severity and that in combination angiotensinogen and renin would be a strong predictor of prognosis at the time of AKI diagnosis. ⋯ The combination of urinary angiotensinogen and renin predicts progression to very severe disease in patients with early AKI after cardiac surgery.
-
Clin J Am Soc Nephrol · Dec 2013
Editorial CommentOpportunities to improve end-of-life care in ESRD.
-
Clin J Am Soc Nephrol · Dec 2013
Comparative StudyMetabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Higher body mass index (BMI) is paradoxically associated with lower mortality in persons with CKD, but whether cardiometabolic abnormalities modulate this association is unclear. ⋯ Metabolic abnormalities may attenuate the magnitude and strength of survival benefits associated with higher BMI in individuals with CKD.
-
Clin J Am Soc Nephrol · Dec 2013
Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting.
The purpose of this study was to determine the accuracy of plasma neutrophil gelatinase-associated lipocalin as a marker of AKI in patients admitted from the emergency department. ⋯ Plasma neutrophil gelatinase-associated lipocalin is an accurate biomarker for prediction of AKI in patients admitted from the emergency department. This work proposes a three-grade classification of AKI risk based on plasma neutrophil gelatinase-associated lipocalin levels.
-
Clin J Am Soc Nephrol · Dec 2013
Multicenter StudySurvival after dialysis discontinuation and hospice enrollment for ESRD.
Textbooks report that patients with ESRD survive for 7-10 days after discontinuation of dialysis. Studies describing actual survival are limited, however, and research has not defined patient characteristics that may be associated with longer or shorter survival times. The goals of this study were to determine the mean life expectancy of patients admitted to hospice after discontinuation of dialysis, and to identify independent predictors of survival time. ⋯ Patients who discontinue dialysis have significantly shorter survival than other hospice patients. Individual survival time varies greatly, but several variables can be used to predict survival and tailor a patient's care plan based on estimated prognosis.